我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Examining the Practice Limitations in Consecutive Treatment Approaches for Pulmonary Arterial Hypertension: An Objective Analysis

Jacob Kaleta

Pulmonary arterial hypertension (PAH) is a progressive and potentially life-threatening condition characterized by elevated blood pressure in the pulmonary arteries, leading to right heart failure and reduced exercise capacity. Over the years, significant advancements have been made in the management of PAH, with a variety of pharmacological treatments available. Consecutive treatment approaches aim to optimize patient outcomes by utilizing multiple therapies in sequence. This review examines the current state of consecutive treatment for PAH, focusing on the practical limitations and the importance of setting clear treatment objectives.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。